Huge positive for Ranbaxy

Latest Strong buzz on streets –

Dilip Sanghvi of Sun Pharma has acquired additional 2% stake in the company in the past 15 days thereby totaling close to 5%.

Sun Pharma and Ranbaxy are going to announce strategic tie up soon .

Ranbaxy will use the FDA approved manufacturing facilities of Sun Pharma to supply drugs to US. In turn Ranbaxy will delist the shares at Rs. 750 per share within a month.

Sources at daichi say that after the recent meeting of commerce ministry, the US FDA officials have assured that the Tonsa plant of Ranbaxy will get approval soon.

SGX Nifty

You may also like...

Discussion on Huge positive for Ranbaxy